The objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each hemiplegic stroke patient in subacute phase, compared to conventional low-frequency rTMS therapy on contralateral M1. Investigators hypothesized that the functional reserve of each hemiplegic stroke patient will be different, and therefore an appropriate simulating target for rTMS therapy is needed. In addition, this approach could be more effective compared to conventional protocols applied to stroke patients regardless of their severity, predicted mechanism of motor function recovery, or functional reserves.
hemiplegic stroke patients in the subacute phase (7 days to 3 months from the onset) who are currently hospitalized,
FMA score of the upper extremity ≤42,
adequate language and cognitive function to perform at least a 1-step obey-command,
pre-stroke functional level of modified Rankin Scale (mRS) ≤1,
those with contraindications to rTMS, such as epilepsy, implanted metal objects in the head, or a history of craniotomy,
those with progressive of hemodynamically unstable medical conditions,
those with coexisting neurological conditions, such as spinal cord injury or Parkinson's disease,
those with major psychiatric disorders, such as major depression, schizophrenia, or dementia,
6
Treatment groupsSee each treatment group below.
Samsung Medical Center
Lead sponsor
National Research Foundation of Korea
Collaborator
Ministry of Food and Drug Safety, Korea
Collaborator
Seoul National University Hospital
Collaborator
Bucheon St. Mary's Hospital
Collaborator
Saint Vincent's Hospital, Korea
Collaborator
Severance Hospital
Collaborator
Kumoh National Institute of Technology
Collaborator
NEUROPHET
Collaborator